ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate

Hamze Timari, Karim Shamsasenjan*, Aliakbar Movassaghpour, Parvin Akbarzadehlaleh, Davod Pashoutan Sarvar, Sara Aqmasheh

Adv Pharm Bull. 2017;7(4): 531-546. doi: 10.15171/apb.2017.065

PMCID: PMC5788208 PMID: 29399543 Scopus ID: 85043400933

Article

PDF

XML

Cited By:

Research Article

2. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study

Gholamreza Shamsaei* , Fatemeh Houshmand, Ahmad Ahmadzadeh Deylami, Armita Valizadeh, Shahram Rafie, Maryam Moradi

Adv Pharm Bull. 2023;13(2): 361-367. doi: 10.34172/apb.2023.043

PMCID: PMC10278208 PMID: 37342380

Article

PDF

Full Text

XML

Cited By:

Research Article

3. The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern-West, Iran

Elaheh Jabbari Hagh, Ali Mousavi, Seyyedeh Mina Hejazian , Mehdi Haghi , Samaneh Esfahanian, Elham Ahmadian , Sepideh Zununi Vahed* , Mohammadreza Ardalan*

Adv Pharm Bull. 2023;13(2): 393-398. doi: 10.34172/apb.2023.038

PMCID: PMC10278212 PMID: 37342387

Article

PDF

Full Text

XML

Cited By:

Review Article

4. Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation

Arsalan Jalili , Abbas Hajifathali, Mozhdeh Mohammadian, Ghazaleh Sankanian, Maryam Sayahinouri, Mahmoud Dehghani Ghorbi, Elham Roshandel* , Nasser Aghdami*

Adv Pharm Bull. 2023;13(3): 469-482. doi: 10.34172/apb.2023.046

PMCID: PMC10460803 PMID: 37646062

Article

PDF

Full Text

XML

Cited By:

Mini Review

5. Potential Applications of Mitochondrial Therapy with a Focus on Parkinson’s Disease and Mitochondrial Transplantation

Pranay Wal* , Ankita Wal, Himangi Vig, Danish Mahmood, Mohd Masih Uzzaman Khan

Adv Pharm Bull. 2024;14(1): 147-160. doi: 10.34172/apb.2024.019

PMCID: PMC10997929 PMID: 38585467

Article

PDF

Full Text

XML

Cited By: